Defunct Company
Total Trials
15
As Lead Sponsor
As Collaborator
0
Total Enrollment
2,189
NCT00687505
Safety Study of FP-1039 To Treat Cancer
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 31, 2008
Completion: Jun 30, 2011
NCT01244438
Study of FP-1039 in Subjects With Endometrial Cancers
Phase: Phase 2
Start: Jan 31, 2011
Completion: Dec 31, 2012
NCT01962337
Phase 1 Single and Multiple Dose Study of FPA008 in Healthy Volunteers and Rheumatoid Arthritis Subjects
Start: Oct 31, 2013
Completion: Apr 30, 2016
NCT02318329
Open-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid Tumors
Start: Nov 30, 2014
Completion: Jun 30, 2019
NCT02471716
Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor
Phase: Phase 1/2
Start: Jun 30, 2015
Completion: Apr 30, 2020
NCT02526017
Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers
Start: Sep 8, 2015
Completion: Nov 18, 2019
NCT03343301
A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer
Start: Nov 30, 2017
Completion: Jan 31, 2019
NCT03514121
FPA150 in Patients With Advanced Solid Tumors
Phase: Early Phase 1
Start: Mar 27, 2018
Completion: Apr 21, 2021
NCT03694522
A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer
Start: Sep 14, 2018
Completion: May 13, 2022
NCT04074759
FPT155 in Patients With Advanced Solid Tumors
Start: Oct 18, 2018
Completion: Aug 10, 2021
NCT06587685
A Study to Assess the Efficacy and Safety of PG-011 Gel in Adolescents and Adults With Atopic Dermatitis
Phase: Phase 3
Start: Mar 15, 2024
Completion: Jan 15, 2026
NCT06837233
A Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis
Start: Mar 12, 2025
Completion: May 31, 2026
NCT07013097
A Phase I Clinical Trial to Evaluate the Single Dose Ascending and Food Effects of PG-033 in Healthy Adults
Start: May 23, 2025
Completion: Dec 31, 2025
NCT07146126
A Phase III Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis
Start: Sep 15, 2025
Completion: Jul 30, 2026